C. Bourgin

ORCID: 0000-0003-4490-8566
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ovarian cancer diagnosis and treatment
  • Intraperitoneal and Appendiceal Malignancies
  • Endometrial and Cervical Cancer Treatments
  • Renal cell carcinoma treatment
  • Uterine Myomas and Treatments
  • Endometriosis Research and Treatment
  • Colorectal and Anal Carcinomas
  • Appendicitis Diagnosis and Management
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Gynecological conditions and treatments
  • PARP inhibition in cancer therapy
  • BRCA gene mutations in cancer
  • Hernia repair and management
  • Tumors and Oncological Cases
  • Urinary and Genital Oncology Studies
  • Multiple and Secondary Primary Cancers
  • Cutaneous Melanoma Detection and Management
  • T-cell and B-cell Immunology
  • Adrenal and Paraganglionic Tumors
  • Cancer Immunotherapy and Biomarkers
  • Diagnosis and treatment of tuberculosis
  • Hepatitis B Virus Studies
  • Health, Medicine and Society
  • Sarcoma Diagnosis and Treatment
  • Chemotherapy-related skin toxicity

Institut de Cancérologie de l'Ouest
2019-2025

Nantes Université
2022

Hôpital Jeanne de Flandre
2018-2019

Hôpital Lyon Sud
2019

Centre Hospitalier Universitaire de Lille
2019

Centre Hospitalier René-Dubos
2019

Centre Jean Perrin
2016-2017

Université de Rennes
2015-2016

Centre Hospitalier Universitaire de Rennes
2015-2016

Inserm
2013

<h3>Objectives</h3> The modeled CA-125 elimination constant K (KELIM) is a pragmatic early marker of tumor chemosensitivity in ovarian cancer patients treated with neoadjuvant chemotherapy before interval surgery. primary objective this study was to assess the prognostic value KELIM regarding feasibility complete surgery, and secondary objectives were for risk platinum resistant relapse, progression free survival, overall survival. <h3>Methods</h3> based on retrospective cohort 284 an...

10.1136/ijgc-2023-004872 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2024-01-19

Abstract Objectives The main prognostic factor for peritoneal metastasis (PM) is the complete resection of disease during cytoreductive surgery. Accurate patient selection therefore essential determining eligibility this type carcinomatosis index (PCI) a widely used tool assessing extent carcinomatosis. This study aimed to evaluate inter-observer reproducibility PCI assessments via laparoscopy and identify factors influencing reproducibility. Methods Between November 2020 2022, 25...

10.1515/pp-2024-0015 article EN cc-by Pleura and Peritoneum 2025-03-01

Objective This study compares two methods of evaluating para‐aortic node involvement in locally advanced cervical cancer ( LACC ) order to define external radiotherapy treatment fields: laparoscopic surgical lymphadenectomy or PET ‐ CT imaging. Population We selected 187 patients with who had been treated by chemoradiation therapy comprehensive centres from January 2001 December 2013. A total 98 underwent evaluation (Centre 1) and 89 received excision 2). Methods All were retrospectively...

10.1111/1471-0528.14492 article EN BJOG An International Journal of Obstetrics & Gynaecology 2017-01-27

The notion of natural killer (NK)-cell education has recently emerged, and accumulating evidence indicates that the terminal differentiation NK cells can be achieved in periphery. This means proper function these lymphocytes is dependent on their environment, opening a new door through which cancer escape immunosurveillance.

10.4161/onci.26688 article EN OncoImmunology 2013-12-01

<h3>Introduction/Background</h3> Para-aortic lymphadenectomy is currently not systematized in the pre-treatment management of advanced cervical cancer (FIGO IB3-IVA). However, metastatic lymph has prognostic and therapeutic importance. We compared morbidity mortality retroperitoneal para-aortic with transperitoneal approach, pre-therapeutic node staging cervix cancers at a locally stage <h3>Methodology</h3> All pre- postoperative data from 331 patients operated for negative Positron Emission...

10.1136/ijgc-2019-esgo.447 article EN 2019-11-01
Coming Soon ...